Aristeia Capital’s Tevogen Inc. Common Stock TVGN Stock Holding History

Aristeia Capital’s Portfolio TVGN Stock Details TVGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-21,000	Closed	-$10.8M	–	402
2022 Q4	$10.8M	Hold	21,000	–	–	0.22%	128
2022 Q3	$10.7M	Hold	21,000	–	–	0.19%	158
2022 Q2	$10.5M	Buy	21,000 +11,000	+110%	+$5.51M	0.19%	151
2022 Q1	$5M	Buy	+10,000	New	+$4.97M	0.09%	247

Other funds holding TVGN

CCP

Corbin Capital Partners New York $61.3M AUM 53.03% 1-Year Est. Return

FCM

FourWorld Capital Management New York $196M AUM 42.39% 1-Year Est. Return

Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Aristeia Capital's TVGN Position: Q1 2023 in Review

Aristeia Capital sold out of Tevogen Inc. Common Stock (TVGN) in Q1 2023, closing a stake of 21,000 shares — an estimated $10.8M sold.

Aristeia Capital first reported a position in TVGN in Q1 2022 and held it in 4 quarters. The position peaked at $10.8M in Q4 2022. 4 funds tracked by Wall St. Rank hold TVGN as of Q1 2023.

Aristeia Capital reported no remaining Tevogen Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
Aristeia Capital sold 21,000 Tevogen Inc. Common Stock shares in Q1 2023, an estimated $10.8M.
Aristeia Capital first reported a position in Tevogen Inc. Common Stock in Q1 2022 and held it in 4 quarters.
Aristeia Capital's Tevogen Inc. Common Stock position peaked at $10.8M in Q4 2022.
4 funds tracked by Wall St. Rank held Tevogen Inc. Common Stock as of Q1 2023.

Based on Aristeia Capital's 13F filing for Q1 2023, filed 16 May 2023.